摘要
目的:探究对合并糖尿病的Graves眼病进行治疗的方法及临床效果。方法:选取于2016年10月至2022年04月临沂市人民医院收治的130例合并糖尿病的Graves眼病患者,随机分为观察组(甲强龙联合甲氨蝶呤治疗)和对照组(甲强龙治疗)各65人。对比两组治疗情况。结果:相比于对照组(78.46%),观察组治疗总有效率(96.92%)较高(P 0.05);观察组临床症状评分低于对照组(P < 0.05);结论:对合并糖尿病的Graves眼病患者运用甲强龙联合甲氨蝶呤治疗,能够提高治疗的疗效,减轻患者临床症状,使其生活质量得到改善。
Objective: To explore the treatment method and clinical effect of Graves eye disease with diabetes mellitus. Methods: A total of 130 patients with Graves’ disease complicated with diabetes who were admitted to Linyi People’s Hospital from October 2016 to April 2022 were randomly divided into observation group (methylprednone plus methotrexate treatment) and control group (methylprednone treatment), 65 in each group. The treatment of the two groups was compared. Results: Compared with the control group (78.46%), the total effective rate of observation group (96.92%) was higher (P 0.05). The clinical symptom score of observation group was lower than that of control group (P < 0.05). Conclusion: The use of methylprednone combined with methotrexate in the treatment of Graves eye disease patients with diabetes can improve the therapeutic effect, relieve the clinical symptoms and improve their quality of life.
出处
《临床医学进展》
2022年第8期7166-7171,共6页
Advances in Clinical Medicine
